Opinion of Advocate General Tesauro delivered on 22 September 1992

1 Original language: Italian.

2 OJ, English Special Edition 1965-66, p. 20.

3 As from 1 January 1992, that obligation was extended to medicinal products which are not proprietary medicinal products (see Council Directive 89/341/EEC of 3 May 1989, OJ 1989 L 142, p. 11).

4 See, most recently, the judgment in Case C-112/89 Upjohn [1991] ECR I-1703, paragraph 18.

5 Judgment in Case 227/82 Van Bennekom [1983] ECR 3883, paragraph 17; similarly, see, most recently, the judgment in Case C-112/89 Upjohn, cited above, paragraph 16.

6 See the judgment in Van Bennekom, cited above, paragraph 18.

7 See, to that effect, the judgment cited in the preceding footnote, the judgment in Case C-369/88 Delatare [1991] ECR I-1487, paragraphs 40 and 41, and the judgment in Case C-60/89 Monteil and Samanni [1991] ECR I-1547, paragraph 23.

8 See, most recently, the judgment in Case C-260/89 Ellimnkt Radiophonia TUeorassi AE [1991] ECR I-2925, paragraph 41.

9 See the judgment in Ellininki Radiophonia Ttleorassi AE, cited above, paragraph 44.

10 Judgment in Case 35/85 Procureur de la République v Tissier [1986] ECR 1207, paragraph 22.